Dufresne C - Search Results

1

Covalent inhibitors design and discovery.

De Cesco S, Kurian J, Dufresne C, Mittermaier AK, Moitessier N. De Cesco S, et al. Among authors: dufresne c. Eur J Med Chem. 2017 Sep 29;138:96-114. doi: 10.1016/j.ejmech.2017.06.019. Epub 2017 Jun 10. Eur J Med Chem. 2017. PMID: 28651155 Review.

2

Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α.

Plescia J, De Cesco S, Patrascu MB, Kurian J, Di Trani J, Dufresne C, Wahba AS, Janmamode N, Mittermaier AK, Moitessier N. Plescia J, et al. Among authors: dufresne c. J Med Chem. 2019 Sep 12;62(17):7874-7884. doi: 10.1021/acs.jmedchem.9b00642. Epub 2019 Aug 22. J Med Chem. 2019. PMID: 31393718

3

Discovery of covalent prolyl oligopeptidase boronic ester inhibitors.

Plescia J, Dufresne C, Janmamode N, Wahba AS, Mittermaier AK, Moitessier N. Plescia J, et al. Among authors: dufresne c. Eur J Med Chem. 2020 Jan 1;185:111783. doi: 10.1016/j.ejmech.2019.111783. Epub 2019 Oct 18. Eur J Med Chem. 2020. PMID: 31732257

4

Modulating the selectivity of inhibitors for prolyl oligopeptidase inhibitors and fibroblast activation protein-α for different indications.

Plescia J, Hédou D, Pousse ME, Labarre A, Dufresne C, Mittermaier A, Moitessier N. Plescia J, et al. Among authors: dufresne c. Eur J Med Chem. 2022 Oct 5;240:114543. doi: 10.1016/j.ejmech.2022.114543. Epub 2022 Jun 17. Eur J Med Chem. 2022. PMID: 35797897

5

Unsafe Care and Fake News in Freeman-Burian Syndrome.

Poling MI, Dufresne CR. Poling MI, et al. Among authors: dufresne cr. Clin Case Rep. 2025 Jan 6;13(1):e70078. doi: 10.1002/ccr3.70078. eCollection 2025 Jan. Clin Case Rep. 2025. PMID: 39776776 Free PMC article.

6

Glycolipid and Lipopeptide Biosurfactants: Structural Classes and Characterization-Rhamnolipids as a Model.

Darwiche N, Dufresne C, Chartier A, Claude B, Colas C, Fougère L, Sebban M, Lucchesi ME, Le Floch S, Nehmé R. Darwiche N, et al. Among authors: dufresne c. Crit Rev Anal Chem. 2024 Dec 29:1-21. doi: 10.1080/10408347.2024.2441428. Online ahead of print. Crit Rev Anal Chem. 2024. PMID: 39734093 Review.

7

A platform of ADAPTive scaffolds: development of CDR-H3 β-hairpin mimics into covalent inhibitors of the PD1/PDL1 immune checkpoint.

Naylon SH, Richaud AD, Zhao G, Bui L, Dufresne CP, Wu CJ, Wangpaichitr M, Savaraj N, Roche SP. Naylon SH, et al. Among authors: dufresne cp. RSC Chem Biol. 2024 Nov 4;5(12):1259-70. doi: 10.1039/d4cb00174e. Online ahead of print. RSC Chem Biol. 2024. PMID: 39552936 Free PMC article.

8

Endogenous Production and Vibrational Analysis of Heavy-Isotope-Labeled Peptides from Cyanobacteria.

Ricca JG, Mayali X, Qu J, Weber PK, Poirier G, Dufresne CP, Louda JW, Terentis AC. Ricca JG, et al. Among authors: dufresne cp. Chembiochem. 2024 Mar 15;25(6):e202400019. doi: 10.1002/cbic.202400019. Epub 2024 Feb 21. Chembiochem. 2024. PMID: 38311594

9

Comment on: anesthetic management of a pediatric patient with Freeman-Sheldon syndrome undergoing atrial septal defect closure: a case report.

Poling MI, Dufresne CR. Poling MI, et al. Among authors: dufresne cr. JA Clin Rep. 2024 Jan 23;10(1):4. doi: 10.1186/s40981-023-00668-y. JA Clin Rep. 2024. PMID: 38261063 Free PMC article. No abstract available.

10

Three-in-one method for high throughput plant multi-omics.

Chhajed S, Lu LL, Mangual G, Zhu W, Dufresne C, Chen S. Chhajed S, et al. Among authors: dufresne c. Methods Enzymol. 2023;683:153-170. doi: 10.1016/bs.mie.2022.08.039. Epub 2022 Nov 11. Methods Enzymol. 2023. PMID: 37087185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters